| Pharmaceutical active ingredients: |
| Pentaerithrityl Tetranitrate |
| Available forms, composition and doses of Pentalong: |
| Tablets; Oral; Pentaerithrityl Tetranitrate 50 mgTablets; Oral; Pentaerithrityl Tetranitrate 80 mg |
| Pentalong medical category: |
| Human:Vasodilating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA05 - Pentaerithrityl Tetranitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alpharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nitropenton | Pentaerithrityl Tetranitrate | Egis |
| Nitro-Riletten | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Nitrotalans | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pencard | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentafin | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentanitrine | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentanitrol | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentanitrolum | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentarit | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pen-Tetra | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |